Kyle A Blum

9PUBLICATIONS
71CO-AUTHORS
Non-Newtonian fluid flows (incl. rheology)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 29, 2026
Comparative Outcomes and Management of Vesicourethral Anastomotic Stenosis After Contemporary Standard and Pelvic-Fascia-Sparing Robotic-Assisted Radical Prostatectomy Techniques.

|Jan 21, 2025
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation.

Sandra L Grimm, Menuka Karki, Kyle A Blum

|Aug 17, 2023
Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified study.

Kyle A Blum, Andrew W Silagy, Andrea Knezevic

|Nov 10, 2022
Complication rates in concurrent inflatable penile prosthesis and incontinence surgery: Comparing the penoscrotal versus perineal incision approach.

Kyle A Blum, Justin P Mehr, Travis P Green

|Jun 27, 2022
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma.

Phillip M Rappold, Lynda Vuong, Josef Leibold

|Jun 15, 2022
Author Correction: Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies.

Emily R Kansler, Saïda Dadi, Chirag Krishna

Pageof 2

Frequent Collaborators

4 joint publications

Fengshen Kuo

3 joint publications

A Ari Hakimi

3 joint publications

Ming O Li

2 joint publications

Christina S Leslie